AMENDMENT TO INVESTMENT MANAGEMENT AGREEMENT BetweenInvestment Management Agreement • September 10th, 2019 • T. Rowe Price U.S. Equity Research Fund, Inc.
This Amendment (the “Amendment”) to the Restated Investment Management Agreement (the “Agreement”) is made as of the 1st day of November, 2019, by and between T. ROWE PRICE U.S. EQUITY RESEARCH FUND INC., a Maryland corporation (the “Corporation”), on behalf of the T. Rowe Price U.S. Equity Research Fund (the “Fund”), a separate series of the Corporation, and T. ROWE PRICE ASSOCIATES, INC., a corporation organized and existing under the laws of the State of Maryland (hereinafter called the “Manager”). Any terms used in this Amendment are defined as defined in the Agreement unless otherwise defined herein.
EXPENSE LIMITATION AGREEMENTExpense Limitation Agreement • September 10th, 2019 • T. Rowe Price U.S. Equity Research Fund, Inc.
This EXPENSE LIMITATION AGREEMENT (the “Agreement”), effective as of November 1, 2019, is entered into between T. Rowe Price Associates, Inc. (the “Manager”), a corporation organized and existing under the laws of the State of Maryland, and T. Rowe Price U.S. Equity Research Fund, Inc. (the “Corporation”), a corporation organized and existing under the laws of the State of Maryland, on behalf of the T. Rowe Price U.S. Equity Research Fund (the “Fund”). This Agreement supersedes the Expense Limitation Agreement between the Manager and the Corporation, on behalf of the Fund, dated November 29, 2016.
